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ABSTRACT
Background: A pollen exposure chamber (OHIO Chamber) was built in central Tokyo, Japan, in order to
study seasonal allergic rhinitis (SAR). Since satisfactory outcomes were obtained from the controlled pollen ex-
posure at the chamber, we conducted preliminary studies in volunteers with SAR.
Methods: Ten volunteers with SAR sensitive to Japanese cedar (JC) pollen were enrolled in this study. In or-
der to investigate the intranasal and intraocular pollen number, volunteers were initially exposed to a low con-
centration of JC (2500 grainsm3) for at most 1 hour in this chamber. Before and after the exposure, nasal cavi-
ties and eyes were washed with 100 ml and 25 ml of saline, respectively. Nasal and eye washing solutions
were collected and the number of JC pollen was counted.
After 3 hours the volunteers were subsequently exposed to a moderate concentration of JC (4500 grainsm3)
for 2 hours. Subjective nasal and ocular symptoms were recorded and the amount of nasal secretion was
measured during the allergen exposure periods.
Results: During the initial exposure, all volunteers except one stayed in the chamber for 1 hour without any
nasal or ocular symptoms. The number of pollen in the nose and eyes was 249.2 ± 120.9 and 13.6 ± 13.6
grains, respectively.
During the subsequent 2-hour exposure to JC pollen, nasal and ocular symptoms developed gradually in a time
dependent manner in all the volunteers except one.
Conclusions: This is the first clinical study using Japanese cedar pollen under well-controlled conditions in
the OHIO chamber in which the induction of allergic symptoms was observed. The OHIO chamber will be use-
ful for studying allergic rhinitis in Japan.
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INTRODUCTION
Japanese cedar (JC) pollinosis is a seasonal allergy,
which is unique to Japan, and the causative allergen
(JC pollen) is dispersed usually between February
and April although the pollen count varies every year.
Over 16% of the Japanese population suffer from the
allergy during this season1 and an incredible amount
of anti-allergy agent is used, resulting in an under-
mined QOL2 and decline in labor productivity.3 This
fact indicates that JC pollinosis is a social and eco-
nomical problem which cannot be ignored.
Allergen exposure tests in natural environments
have been conducted as fundamental research on this
kind of allergy and also to examine the effectiveness
of anti-allergy agents.4,5 Studies of this sort, however,
are greatly influenced by natural factors such as the
amount of pollen, the weather, the temperature, or
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Fig. 1 Appearance of the artificial exposure chamber 
(OHIO Chamber). Polen-difuser in the center (arow). 
Blower module in the corner of the room (arow head)
Fig. 2 Spatial concentration distributions of polen in the 
OHIO Chamber at a height of 1.15 m at the target concentra
tion of 3500 grains/m3. The average concentration of polen 
was 3500 ± 419 grains/m3.
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the wind velocity. The biggest problem is that the
tests can be done only during the pollen season.
Several allergen exposure units have been built in
Europe and the US to evaluate the efficacy of drugs
and they are operating safely and effectively.6-8 A pre-
defined amount of pollen can be dispersed under sta-
ble conditions in these chambers.
Despite the fact that so many Japanese are allergic
to JC pollen, this kind of chamber was not available in
Japan before 2004. To meet the increased needs for
such facilities, the first pollen exposure units in Japan
were developed in Wakayama9 in the first half of
2005. We built the third allergen exposure chamber,
an artificial exposure chamber (AEC; OHIO Cham-
ber), in the center of Tokyo in September, 2005. This
chamber not only keeps the temperature and humid-
ity constant, but also automatically cleans and dries
the inside of the chamber.
Due to the lack of AECs in Japan, little fundamental
data concerning Japanese cedar pollinosis were avail-
able up to this point. Since satisfactory outcomes
were obtained from the controlled exposure at the
OHIO Chamber, we were able to conduct preliminary
studies on mildly symptomatic patients, in which we
examined the amount of intranasal and intraocular
pollen grains and the development of symptoms.
METHODS
SUBJECTS
The subjects of our study were mildly symptomatic
adult patients. The inclusion criteria were as follows:
・ Subjects must have at least a 2-year history of al-
lergic symptoms during the pollen season, such as
sneezing, nasal discharge, nasal obstruction, and
itchy eyes.
・ Subjects must also have had blood tests within
1.5 years showing positive RAST scores (Class 2)
for JC pollen and negative RAST scores (Class 1)
for house dust mite.
The exclusion criteria were as follows:
・ Subjects with nasal obstruction attributable to a
polyp or deformity of the nose.
・ Subjects with acute upper respiratory infec-
tion(s) such as acute sinusitis, acute pharyngitis, and
acute upper respiratory inflammation.
・ Subjects with uncontrolled asthma, diabetes,
high blood pressure, or eye diseases (glaucomacata-
ract).
・ Subjects who used anti-allergy agent(s) within a
week before the start of this study.
・ Pregnant women or women who trying to be-
come pregnant.
The study was conducted in accordance with GCP
Guidelines and the Declaration of Helsinki. The study
was conducted on December 23 (2 months ahead of
the start of the pollen season) after having been re-
viewed and approved by the ethics committee of Shi-
nanozaka Clinic. Informed consent was obtained from
all the subjects prior to study entry.
OHIO CHAMBER
The OHIO Chamber was installed in Samoncho
Clinic in Yotsuya, the center of Tokyo. Its square
measure is 25 m2, the height 2.5 m, and the capacity
10 subjects (Fig. 1).
Compressed air transfers pollen grains from an
outside dust feeder into the operation room where it
is mixed with conditioned air inside the pollen dif-
fuser after which the mixed air jets out upward from
the diffuser. The diffuser and the blower modules in
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Fig. 3 The polen concentration at a height of 1.15 m at 
the four points (●) when the ten volunteers (○) were pre
sent in the OHIO chamber. The average concentration was 
3380 grains/m3 and uniform distribution of polen was 
achieved.
operation room
3172 grains/m3
3500 grains/m3
3299 grains/m3
average concentration: 3380 grains/m3
3547 grains/m3
AS ASWC
WC: toilet AS: air shower
Table 1 Backgrounds of the subjects.
RAST scoreAgeSexSubject No.
337female 1
535female 2
434male 3
345male 4
236male 5
434female 6
241male 7
232female 8
343female 9
248male10
Five men and five women with mild symptoms were enroled 
in this study.
This table shows their age and antibody titers (RAST scores) 
against cedar polen.
four corners help the pollen grains get distributed
evenly. The concentration of pollen grains in the
room is measured by a particle counter equipped
with a semiconductor laser (KC-20; Rion Co, Tokyo,
Japan). This counter can absorb up to 30 L of air per
minute and detects particles sized 10―100 μm.
Spatial distributions of pollen in the unmanned and
manned chamber at a height of 1.15 m were meas-
ured. The pollen concentration distribution was
within a range of ± 12% of the target value of 3500
grainsm3 in the unmanned chamber (Fig. 2). The
pollen number at each of four points and the average
pollen concentration are shown in Figure 3 when 10
subjects were present in the chamber.
The pollen count in this room is stable between
2500 and 120000 grainsm3 (data not shown). Also,
the temperature inside the chamber was set at 22 ±
0.2℃ and the humidity was set about 20―55%. The
pollen count, temperature, and humidity were moni-
tored every 3 minutes and recorded accordingly.
Before entering the room, subjects were instructed
to wear protection gowns so that the pollen grains
were not attached to their hair or clothes. When en-
tering or exiting, they also went through an air
shower so as to avoid pollen grain contamination out-
side of the room. During the test, subjects were as-
signed to sit on chairs in designated areas of the
chamber and in order to ensure the subjects’ safety,
their behavior was observed closely by staff and phy-
sicians situated in the operating room.
STUDY DESIGN
This study consisted of two parts. In the first part,
subjects were exposed to low-concentrated JC pollen
(2500 grainsm3) in the chamber for up to an hour.
They were allowed to exit the room if allergic symp-
toms developed (either in the nose or in the eyes).
Immediately after exiting the room, all the subjects
went through an intranasal and intraocular irrigation
process using a syringe (Nasaline®; Entpro, Sweden),
washing the nasal cavities with 100 ml of saline and
the eyes with 25 ml of saline. Then the washing solu-
tion from each subject was collected to investigate
the number of pollen grains in it.
The subjects were subsequently exposed to
moderate-concentrated JC pollen (4500 grainsm3)
for 2 hours. Each subject recorded their symptoms
(such as sneezing, nasal discharge, nasal obstruction,
itchy nose, itchy eyes, and tears) into computers at
certain points (after 15, 30, 60, 90, and 120 minutes
from the start of exposure).
The symptoms were classified as follows: 1. none,
2. mild, 3. moderate, 4. severe, and 5. very severe. We
collected tissue papers with which subjects had
blown their noses and measured them by weight.
The weight difference between tissue papers before
and after use was considered to be the weight of na-
sal secretion.
The amount of intranasal and intraocular pollen
was determined by the following methods. We added
1.25 g of Safranine-O (Wako Jyunnyaku Kogyo Inc.
Tokyo) to 50 ml of saline and 50 ml of ethanol to cre-
ate stain solutions, and 5 ml of this stain solution was
added to the nasal or ocular lavage fluid. Further-
more, we added 20 drops of Proteinase K (Dako Cy-
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Table 2 The number of intraocular and intranasal polen grains in the first part of the study.
Mean ± SD10987654 3＊21Subject No.#
13.6 ± 13.6 (grains) 10 49  612 20 15  6  3 13  2Intraocular polen
249.2 ± 120.9 (grains)32828126090522198160303175175Intranasal polen
One subject (＊) exited the chamber 10 min earlier since she was about to sneeze.
The remaining subjects were able to stay for an hour without developing symptoms.
# As to the subject numbers, see Table 1
Table 3 The number of subjects who showed nose or eye symptoms during 2-hour alergen exposure.
(min)12090603015
86331Rhinorhea
44110Sneezing
76641Nasal obstruction
87442Nasal itching
67652Eye itching
33320Watery eyes
0.73 ± 0.830.23 ± 0.39Nasal secretion (g/hr)
There were increases in the number of subjects who developed nasal and ocular symptoms in a time dependent manner. Six subjects 
developed nasal obstruction after 60 minutes of exposure, of which 3 subjects marked their symptoms as moderate while 1 subject 
marked them as severe. Although 8 subjects developed rhinorhea and nasal itching after 2 hours of exposure to the alergen, only 4 sub-
jects developed sneezing and their symptoms were mild. We measured the amount of nasal secretion from 3 subjects in the first half of 
the study and from 7 in the later half of the study. Ocular symptoms also developed as time went by. During the study period, 1 subject 
showed neither nasal nor ocular symptoms.
tomation Inc, Tokyo, Japan) to nasal lavage fluid in
order to reduce its viscosity. After shaking the nasal
or ocular lavage fluid for 5 minutes at room tempera-
ture, it was put into a suction filtration device using
0.5 μm filter papers (Advantee Cellulose Nitrate,
Toyo Roshi Inc, Tokyo, Japan). Hereafter, the leftover
solution was washed once more with saline and the
solution was put into a suction filtration device to
keep any single grain from being left behind. In this
way, all the filter papers were examined under a light
microscope (×100) and the pollen count was re-
corded.
RESULTS
The subjects consisted of 5 men and 5 women with
mild symptoms. Their ages ranged from 32 to 48
years (the average age was 38.5 ± 5.4). Background
factors of the subjects are shown in Table 1.
In the first part of this study, the temperature, the
humidity, and the concentration of pollen grains in
the room were kept within the targeted values. That
is, the average number of pollen grains was 2572.8 ±
264.5 grains m3, the average temperature 22.1 ±
0.14℃, and the average humidity 44.7 ± 0.48% (Fig.
4). Intranasal pollen counts in the subjects ranged
from 90 to 522 and intraocular grains ranged from 2
to 49. No relation was seen between the positions of
the subjects within the chamber and the numbers of
pollen detected in the nose and eyes. Even though 1
subject had to leave the chamber 10 minutes earlier
than the scheduled time because of symptom devel-
opment, the rest of the subjects were able to stay in
the room for an hour without developing symptoms.
The average number of intranasal pollen grains and
intraocular grains was 249.2 ± 120.9 and 13.6 ± 13.6,
respectively (Table 2).
In the second part of this study, the temperature,
the humidity, and the concentration of pollen grains
inside the chamber were within targeted values: the
average number of pollen grains was 4367 ± 207
grainsm3, the temperature 22.2 ± 0.35℃, and the hu-
midity 44.8 ± 0.65% (Fig. 5). As time went by, more
and more subjects started developing nasal symp-
toms such as nasal discharge, sneezing, nasal ob-
struction, and itchy nose. Only 3 subjects showed na-
sal discharge 60 minutes after the start of exposure,
but 6 subjects after 90 minutes and 8 subjects after
120 minutes. Likewise, the number of subjects who
developed nasal obstruction increased after 60 min-
utes of exposure, of which 3 subjects marked their
symptoms as moderate while 1 subject marked se-
vere. Although 8 subjects showed nasal itching after
120 minutes, only 4 subjects developed sneezing dur-
ing exposure and their symptoms were mild. Three
subjects blew their nose within 1 hour of the first half
of the study, and 7 in the latter half. The amount of
nasal secretion in the first half and the latter half of
the study was 0.23 ± 0.39 ghour and 0.73 ± 0.83 g
Japanese Cedar Pollinosis and the OHIO Chamber
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Fig. 4 The polen count (a) and temperature and humidity 
(b) in the chamber during the first part of the study. The pol
len count at each point shows the average value during 15 
minutes. The average number of polen grains was 
2572.8 ± 264.5 grains/m3, the average temperature 22.1 ± 
0.14℃, and the average humidity 44.7 ± 0.48%.
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Fig. 5 The polen count (a) and temperature and humidity 
(b) in the chamber during the second part of the study. The 
average number of polen grains was 4367 ± 207 grains/ 
m3, the average temperature 22.2 ± 0.35℃, and the aver
age humidity 44.8 ± 0.65%.
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hour respectively (Table 3).
With regard to ocular symptoms, half of the sub-
jects developed itchy eyes within 30 minutes after en-
tering the chamber, increasing to 7 subjects as time
went by. Their symptoms, however, were mild. In ad-
dition, only 3 subjects developed epiphora while
other 3 subjects experienced neither itchy eyes nor
epiphora in the chamber. During the 2-hour exposure
to pollen, 1 subject showed no nasal or ocular symp-
toms. No adverse event was observed in these stud-
ies. None of the subjects showed late nasal reaction
after returning home.
DISCUSSION
This is a preliminary study showing the amount of in-
tranasal or intraocular pollen as well as allergy symp-
toms in mildly symptomatic subjects with JC pollino-
sis under well controlled conditions in an OHIO
chamber.
There are several allergen exposure units in
Europe and the US6-8 and a lot of useful data are avail-
able in the treatment of allergic rhinitis.10,11 However
it is difficult to simply compare the figures for pollen
dispersal between the results obtained from each ex-
posure unit. Each chamber uses a different method to
count the pollen grains. For instance, our OHIO
chamber uses KC-20 (Rion Co, Tokyo, Japan), a laser
particle counter which measures the number of parti-
cles between 10 and 100 m in diameter. On the other
hand, the Japanese Environment Ministry, which has
been measuring pollen counts at various stations and
providing information during pollen seasons, uses a
different kind of laser-counter (KH-3000: Yamato Sei-
sakujo, Japan). We attempted measurements with
both KC-20 and KH-3000 and discovered that there is
a correlation between the outcomes of the two meth-
ods of measurement. We also discovered that KC-20
yields values 5.9 times larger than those obtained us-
ing KH-3000 (data not shown).
In the first part of the study, subjects were exposed
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to 2500 grainsm3 of JC pollen, which is equivalent to
the amount of airborne pollen grains in the early
stages of the pollen season. Although their allergic
symptoms were reported to be mild, one of the sub-
jects had to leave the room before the scheduled time
since the subject was about to sneeze. The other 9
subjects were able to remain in the room for an hour
without developing any allergic symptoms. We found
that the average number of intranasal and intraocular
pollen grains was 249.2 and 13.6, respectively. The
subjects sat still during the study for up to 1 hour and
did not move around, so their eyes simply received
pollen grains, and their shedding tears and blinking
cleared the pollen grains. On the other hand, subjects
actively inhaled pollen grains through their noses, al-
lowing more pollen to precipitate in the nose and they
did neither sneeze nor blow their noses. These could
be the possible reason why the number of intranasal
pollen grains was much larger than that of the in-
traocular pollen grains. Gotoh et al.12 conducted a
study on the ratio of intranasal to intraocular pollen
numbers, which were obtained from healthy volun-
teers walking in the open air at an ordinary speed for
half an hour. Their study showed the almost same re-
sult with ours.
In the second part of the study, the concentration
of pollen dispersed was increased to 4500 grainsm3.
This concentration is equivalent to the amount of air-
borne pollen grains during the midterm and late
stages of the pollen season. Nasal and ocular symp-
toms gradually developed in a time dependent man-
ner, but these symptoms were mild.
Okuda et al.13 measured the number of intranasal
grains of JC pollinosis patients during pollen seasons
over several years. They showed that the average
number of JC pollen found in a patient’s nose was
about 20, although the amount of pollen varies every
year. They concluded that 90 to 150 pollen grains
were considered to be sufficient to cause symptoms
from the dynamic study of pollen in the nose.
In this study, we found that 90 to 500 pollen grains
in the nose were not enough to develop nasal symp-
toms. The only exception was the subject who exited
the room in 50 minutes due to sneezing, whose in-
tranasal pollen counted 303. There is a difference in
the number of pollen which develops nasal symptoms
observed in our study and in the study conducted in a
natural environment.13 The following could be the
reason for the difference; subjects in this study were
mildly symptomatic patients with JC pollen; subjects
had not received repetitive exposure to JC pollen, be-
cause the study was conducted 3 months ahead of
the pollen season; and subjects were under psycho-
logical pressure since they had never experienced an
environmental exposure study.
This is the first study to show the intranasal and in-
traocular pollen grains and allergic symptoms using
the OHIO Chamber. As far as pollinosis is concerned,
however, our data cannot be immediately generalized
since the results depend on the amount of pollen, the
priming effects of the nasal mucosa, and the severity
of the patients’ symptoms. We need to evaluate the
results of our data carefully. Therefore, further inves-
tigations are required to decide an appropriate
amount of pollen and exposure time to obtain repro-
ducible results and to secure the safety of the sub-
jects.
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